Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell × Everolimus × Clear all

NCT04305444 2025-01-08

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Leukemia, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01665768 2021-10-26

Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

Phase 2 Completed

56 enrolled 10 charts

Lymphoid

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT00702052 2021-05-25

PILLAR-1

Phase 2 Completed

58 enrolled 11 charts

Lymphoid

Lymphoma, Lymphoma, B-Cell, Lymphoma, Mantle-Cell